Literature DB >> 30883192

Loss of Microbial Topography between Oral and Nasopharyngeal Microbiota and Development of Respiratory Infections Early in Life.

Wing Ho Man1,2, Melanie Clerc3, Wouter A A de Steenhuijsen Piters1,4,3, Marlies A van Houten2, Mei Ling J N Chu1,4, Jolanda Kool5, Bart J F Keijser5,6, Elisabeth A M Sanders1, Debby Bogaert1,3.   

Abstract

Rationale: The respiratory microbiota is increasingly being appreciated as an important mediator in the susceptibility to childhood respiratory tract infections (RTIs). Pathogens are presumed to originate from the nasopharyngeal ecosystem.
Objectives: To investigate the association between early life respiratory microbiota and development of childhood RTIs.
Methods: In a prospective birth cohort (Microbiome Utrecht Infant Study: MUIS), we characterized the oral microbiota longitudinally from birth until 6 months of age of 112 infants (nine regular samples/subject) and compared them with nasopharyngeal microbiota using 16S-rRNA-based sequencing. We also characterized oral and nasopharynx samples during RTI episodes in the first half year of life.Measurements and Main
Results: Oral microbiota were driven mostly by feeding type, followed by age, mode of delivery, and season of sampling. In contrast to our previously published associations between nasopharyngeal microbiota development and susceptibility to RTIs, oral microbiota development was not directly associated with susceptibility to RTI development. However, we did observe an influx of oral taxa, such as Neisseria lactamica, Streptococcus, Prevotella nanceiensis, Fusobacterium, and Janthinobacterium lividum, in the nasopharyngeal microbiota before and during RTIs, which was accompanied by reduced presence and abundance of Corynebacterium, Dolosigranulum, and Moraxella spp. Moreover, this phenomenon was accompanied by reduced niche differentiation indicating loss of ecological topography preceding confirmed RTIs. This loss of ecological topography was further augmented by start of daycare, and linked to consecutive development of symptomatic infections.Conclusions: Together, our results link the loss of topography to subsequent development of RTI episodes. This may lead to new insights for prevention of RTIs and antibiotic use in childhood.

Entities:  

Keywords:  child; development; respiratory microbiota; respiratory tract infections; risk factors

Mesh:

Year:  2019        PMID: 30883192     DOI: 10.1164/rccm.201810-1993OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

1.  Epigenetic landscape links upper airway microbiota in infancy with allergic rhinitis at 6 years of age.

Authors:  Andréanne Morin; Chris G McKennan; Casper-Emil T Pedersen; Jakob Stokholm; Bo L Chawes; Ann-Marie Malby Schoos; Katherine A Naughton; Jonathan Thorsen; Martin S Mortensen; Donata Vercelli; Urvish Trivedi; Søren J Sørensen; Hans Bisgaard; Dan L Nicolae; Klaus Bønnelykke; Carole Ober
Journal:  J Allergy Clin Immunol       Date:  2020-07-18       Impact factor: 10.793

2.  Oral application of vancomycin alters murine lung microbiome and pulmonary immune responses.

Authors:  Stefan Pfeiffer; Gregor Jatzlauk; Joni V Lund; Eistine Boateng; Draginja Kovacevic; Machteld N Hylkema; Sabine Bartel; Michael Schloter; Susanne Krauss-Etschmann
Journal:  Immun Inflamm Dis       Date:  2022-08

3.  Early-life viral infections are associated with disadvantageous immune and microbiota profiles and recurrent respiratory infections.

Authors:  Rebecca L Watson; Emma M de Koff; Wouter A A de Steenhuijsen Piters; Raiza Hasrat; Kayleigh Arp; Mei Ling J N Chu; Pieter C M de Groot; Marlies A van Houten; Elisabeth A M Sanders; Debby Bogaert
Journal:  Nat Microbiol       Date:  2022-01-20       Impact factor: 17.745

4.  Nasal microbiota dominated by Moraxella spp. is associated with respiratory health in the elderly population: a case control study.

Authors:  Ellen H A van den Munckhof; Harriet C Hafkamp; Josephine de Kluijver; Ed J Kuijper; Maurits N C de Koning; Wim G V Quint; Cornelis W Knetsch
Journal:  Respir Res       Date:  2020-07-14

5.  Dolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota.

Authors:  Silvio D Brugger; Sara M Eslami; Melinda M Pettigrew; Isabel F Escapa; Matthew T Henke; Yong Kong; Katherine P Lemon
Journal:  mSphere       Date:  2020-09-09       Impact factor: 4.389

6.  Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG.

Authors:  Ogan K Kumova; Adam J Fike; Jillian L Thayer; Linda T Nguyen; Joshua Chang Mell; Judy Pascasio; Christopher Stairiker; Leticia G Leon; Peter D Katsikis; Alison J Carey
Journal:  PLoS Pathog       Date:  2019-10-11       Impact factor: 6.823

7.  Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection.

Authors:  Claire Roubaud-Baudron; Victoria E Ruiz; Alexander M Swan; Bruce A Vallance; Ceren Ozkul; Zhiheng Pei; Jackie Li; Thomas W Battaglia; Guillermo I Perez-Perez; Martin J Blaser
Journal:  mBio       Date:  2019-12-24       Impact factor: 7.867

8.  Associations Between Salivary Bacteriome Diversity and Salivary Human Herpesvirus Detection in Early Childhood: A Prospective Cohort Study.

Authors:  Freida Blostein; Sydney Foote; Elizabeth Salzman; Daniel W McNeil; Mary L Marazita; Emily T Martin; Betsy Foxman
Journal:  J Pediatric Infect Dis Soc       Date:  2021-09-23       Impact factor: 5.235

Review 9.  ERS International Congress, Madrid, 2019: highlights from the Basic and Translational Science Assembly.

Authors:  Niki D Ubags; Jonathan Baker; Agnes Boots; Rita Costa; Natalia El-Merhie; Aurélie Fabre; Alen Faiz; Irene H Heijink; Pieter S Hiemstra; Mareike Lehmann; Silke Meiners; Sara Rolandsson Enes; Sabine Bartel
Journal:  ERJ Open Res       Date:  2020-03-02

10.  Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life.

Authors:  Susana Fuentes; Debby Bogaert; Marta Reyman; Marlies A van Houten; Debbie van Baarle; Astrid A T M Bosch; Wing Ho Man; Mei Ling J N Chu; Kayleigh Arp; Rebecca L Watson; Elisabeth A M Sanders
Journal:  Nat Commun       Date:  2019-11-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.